Tenet Healthcare (NYSE:THC) Now Covered by Analysts at Morgan Stanley
Stock analysts at Morgan Stanley started coverage on shares of Tenet Healthcare (NYSE:THC – Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat reports. The firm set an “overweight” rating and a $165.00 price target on the stock. Morgan Stanley’s price objective would suggest a potential upside of 22.76% […]
